Ignite Creation Date:
2024-05-06 @ 5:12 PM
Last Modification Date:
2024-10-26 @ 2:23 PM
Study NCT ID:
NCT05223673
Status:
TERMINATED
Last Update Posted:
2024-03-05
First Post:
2022-01-25
Brief Title:
Phase 3 Study of FutuximabModotuximab in Combination With TrifluridineTipiracil Versus TrifluridineTipiracil Single Agent in Participants With Previously Treated Metastatic Colorectal Cancer
Sponsor:
Institut de Recherches Internationales Servier
Organization:
Servier
Organization Data
Organization:
Servier
Class:
INDUSTRY
Study ID:
CL3-95026-001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Institut de Recherches Internationales Servier
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| ADIR a Servier Group company | INDUSTRY |